BioCanRx has set the next intake date for funding applications in its rolling, open call process. BioCanRx builds on past and ongoing investments in the area of cancer biotherapeutics that have a clear path to, or are ready for, clinical trials. They are strengthening Canada’s ability to translate the unfolding promise of immune-based cancer therapies into benefits for patients.

As an open call, this opportunity is open to all investigators located at Canadian institutions eligible to receive peer-reviewed funding from the three federal research-granting councils (CIHR, SSHRC, NSERC).

Important Date:

The next intake deadline is November 9, 2016, by 11:59 p.m. EDT

If you have questions regarding your eligibility (or that of your institution) or how your project would fit within our research program, you are encouraged to contact Dr. Kelley Parato, Director of Scientific Affairs at BioCanRx.

For more information, see the Apply for Funding page at the BioCanRx website or contact:

Dr. Kelley Parato
Tel: 613-739-5200